BR112019007478A2 - um novo método para a produção de sulfato de cálcio hemihidratado com propriedades únicas - Google Patents

um novo método para a produção de sulfato de cálcio hemihidratado com propriedades únicas

Info

Publication number
BR112019007478A2
BR112019007478A2 BR112019007478A BR112019007478A BR112019007478A2 BR 112019007478 A2 BR112019007478 A2 BR 112019007478A2 BR 112019007478 A BR112019007478 A BR 112019007478A BR 112019007478 A BR112019007478 A BR 112019007478A BR 112019007478 A2 BR112019007478 A2 BR 112019007478A2
Authority
BR
Brazil
Prior art keywords
calcium sulfate
unique properties
sulfate hemihydrate
new method
producing calcium
Prior art date
Application number
BR112019007478A
Other languages
English (en)
Other versions
BR112019007478B1 (pt
Inventor
Axén Niklas
Gruden Stefan
Original Assignee
Lidds Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57178277&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112019007478(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lidds Ab filed Critical Lidds Ab
Publication of BR112019007478A2 publication Critical patent/BR112019007478A2/pt
Publication of BR112019007478B1 publication Critical patent/BR112019007478B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00—Compounds of calcium, strontium, or barium
    • C01F11/46—Sulfates
    • C01F11/466—Conversion of one form of calcium sulfate to another
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B11/00—Calcium sulfate cements
    • C04B11/02—Methods and apparatus for dehydrating gypsum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Geology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Ceramic Engineering (AREA)
  • Urology & Nephrology (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

a presente invenção se refere a um novo método para produzir um sulfato de cálcio hemihidratado com propriedades únicas para uso em aplicações terapêuticas na indústria cosmética ou farmacêutica. o sulfato de cálcio hemihidratado é uma substância inorgânica biocompatível e biodegradável e, portanto, adequado como carreador em composições farmacêuticas, por exemplo, uma composição de liberação controlada, contendo pelo menos um ingrediente farmaceuticamente ativo.
BR112019007478-3A 2016-10-17 2017-10-16 Método para a produção de sulfato de cálcio hemi-hidratado em pó e sulfato de cálcio hemi-hidratado em pó obtido BR112019007478B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16194209 2016-10-17
EP16194209.9 2016-10-17
PCT/EP2017/076325 WO2018073165A1 (en) 2016-10-17 2017-10-16 A new method for producing calcium sulphate hemihydrate with unique properties

Publications (2)

Publication Number Publication Date
BR112019007478A2 true BR112019007478A2 (pt) 2019-07-16
BR112019007478B1 BR112019007478B1 (pt) 2023-10-03

Family

ID=57178277

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019007478-3A BR112019007478B1 (pt) 2016-10-17 2017-10-16 Método para a produção de sulfato de cálcio hemi-hidratado em pó e sulfato de cálcio hemi-hidratado em pó obtido

Country Status (20)

Country Link
US (2) US10351437B2 (pt)
EP (2) EP3331826B1 (pt)
JP (1) JP7088919B2 (pt)
KR (1) KR102408805B1 (pt)
CN (1) CN109843807B (pt)
AU (1) AU2017344893B2 (pt)
BR (1) BR112019007478B1 (pt)
CA (1) CA3038699A1 (pt)
DK (1) DK3331826T3 (pt)
ES (1) ES2778109T3 (pt)
HK (1) HK1253356B (pt)
HU (1) HUE043269T2 (pt)
IL (1) IL266008B (pt)
MX (1) MX2019004414A (pt)
PL (1) PL3331826T3 (pt)
RU (1) RU2753343C2 (pt)
SG (1) SG11201902825RA (pt)
TR (1) TR201905353T4 (pt)
WO (1) WO2018073165A1 (pt)
ZA (1) ZA201902949B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3331826B1 (en) * 2016-10-17 2019-02-27 Lidds AB A new method for producing calcium sulphate hemihydrate with unique properties
WO2023189062A1 (ja) 2022-03-31 2023-10-05 日清食品ホールディングス株式会社 栄養付加食の製造方法及び栄養付加食の提供方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956456A (en) * 1971-12-17 1976-05-11 National Gypsum Company Gypsum calcination
DE3141746A1 (de) * 1981-10-21 1983-05-05 Börgardts-Sachsenstein GmbH, 3425 Walkenried Kosmetische zubereitung und verfahren zu ihrer herstellung
GB2205089B (en) * 1987-05-22 1991-03-13 Rhein Westfael Elect Werk Ag Process for production of calcium sulphate alpha-hemihydrate
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
DE19620117C1 (de) * 1996-05-18 1997-07-24 Corimed Kundenorientierte Medi Verfahren zur Herstellung eines calciumsulfathaltigen medizinischen Präparats und calciumsulfathaltiges medizinisches Präparat
JP2003508420A (ja) * 1999-09-02 2003-03-04 ノストラム・ファーマスーティカルズ・インコーポレイテッド 経口投与に適した、制御された放出の経口用量
JP2002249317A (ja) 2001-02-20 2002-09-06 Noritake Co Ltd 半水石膏の製造方法
DK1996160T3 (da) 2006-03-14 2010-07-05 Lidds Ab Bioresorberbar sammensætning med kontrolleret frigivelse
EP2061731B1 (en) * 2006-12-20 2020-04-15 Gypsum Technologies Inc. Calcium sulfate hemihydrate treatment process
DE102007024188B3 (de) * 2007-05-24 2008-04-10 Grenzebach Bsh Gmbh Verfahren zur Herstellung von Alpha-Calciumsulfat-Halbhydrat aus Calciumsulfat-Dihydrat und zugehörige Vorrichtung
CN101691286B (zh) * 2009-10-12 2011-09-07 孙恩光 α型半水石膏蒸压釜及其生产方法
WO2012054009A1 (en) * 2010-10-19 2012-04-26 Jiin-Huey Chern Lin Method for preparing a hardened calcium sulfate dihydrate block and use thereof
US8586074B2 (en) * 2011-02-08 2013-11-19 Orthogen, Llc Calcium sulfate composite particles including aggregated calcium sulfate nanoparticles and method of use for bone augmentation
EP2836195B1 (en) * 2012-04-11 2021-03-10 Induce Biologics Inc. System and method for multiphasic release of growth factors
EP2662329A1 (en) * 2012-05-11 2013-11-13 Creachem SA Peroxygen release compositions and method for producing them
EP2894135A1 (en) 2014-01-10 2015-07-15 Saint-Gobain Placo SAS Method of curing a gypsum calcination product
US9895354B2 (en) * 2014-04-04 2018-02-20 University Of Kentucky Research Foundation Bilayered calcium sulfate/calcium phosphate space-making composites with multiple drug delivery capabilities
CN104310830B (zh) * 2014-10-21 2017-06-06 金正大生态工程集团股份有限公司 一种用磷石膏生产β‑高纯石膏粉的方法
EP3331826B1 (en) * 2016-10-17 2019-02-27 Lidds AB A new method for producing calcium sulphate hemihydrate with unique properties
CN107055586A (zh) * 2016-12-30 2017-08-18 宁夏东吴农化有限公司 一种硫酸钙的制备方法

Also Published As

Publication number Publication date
EP3498675A1 (en) 2019-06-19
US10611646B2 (en) 2020-04-07
EP3331826B1 (en) 2019-02-27
IL266008A (en) 2019-06-30
HK1253356A1 (zh) 2019-06-14
WO2018073165A1 (en) 2018-04-26
BR112019007478B1 (pt) 2023-10-03
RU2019112298A (ru) 2020-11-17
ZA201902949B (en) 2020-12-23
CA3038699A1 (en) 2018-04-26
IL266008B (en) 2022-08-01
RU2753343C2 (ru) 2021-08-13
KR20190089854A (ko) 2019-07-31
EP3331826A1 (en) 2018-06-13
AU2017344893B2 (en) 2021-09-09
JP2019532006A (ja) 2019-11-07
CN109843807B (zh) 2021-12-14
AU2017344893A1 (en) 2019-05-02
US10351437B2 (en) 2019-07-16
KR102408805B1 (ko) 2022-06-14
MX2019004414A (es) 2019-09-02
PL3331826T3 (pl) 2019-08-30
TR201905353T4 (tr) 2019-05-21
DK3331826T3 (da) 2019-05-27
ES2778109T3 (es) 2020-08-07
CN109843807A (zh) 2019-06-04
SG11201902825RA (en) 2019-05-30
JP7088919B2 (ja) 2022-06-21
US20190119122A1 (en) 2019-04-25
HUE043269T2 (hu) 2019-08-28
RU2019112298A3 (pt) 2020-12-22
US20190345038A1 (en) 2019-11-14
HK1253356B (zh) 2020-02-07

Similar Documents

Publication Publication Date Title
NI201700011A (es) 2-(morfolin-4-il)-1,7-naftiridinas.
BR112017023764A2 (pt) derivados de ciclohexano substituído por amido
PE20170150A1 (es) (2r,5s,13ar)-7,9-dioxo-10-((2,4,6-trifluorobencil)carbamoil)-2,3,4,5,7,9,13,13a-octahidro-2,5-metanopirido[1´,2’:4,5]pirazino[2,1-b][1,3]oxazepin-8-olato de sodio
BR112017016503A2 (pt) conjugado de fármaco de citotoxicidade-ligante, método de preparação para o mesmo, e aplicação para o mesmo
CO2022007005A2 (es) Aminoquinolonas sustituidas como inhibidores de dgk alfa para la activación inmune
CL2010001260A1 (es) Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis.
UY33246A (es) Tienopirimidinas que contienen cicloalquilo para composiciones farmacéuticas
ECSP13012573A (es) 6-amino-nicotinamidas sustituidas como moduladores de KCNQ2/3
BR112017012714A2 (pt) composição de liberação modificada, método para tratamento ou prevenção de uma doença ou condição, e, método cosmético para reduzir peso corporal.
BR112017006406A2 (pt) composições e métodos para o tratamento e profilaxia de infecções de sítio cirúrgico
BR112015019981A2 (pt) configuração melhorada de substituto ósseo rígido
EA201890193A1 (ru) Композиция для ухода за полостью рта
UY35848A (es) Tienopirimidinas
BR112014011260A8 (pt) material de multicamadas, método para a preparação de um material de multicamadas, implante ou prótese para uma estrutura óssea ou dentária, uso de um material de multicamadas e composição de implante para uma estrutura óssea
BR112018008388A2 (pt) composição compreendendo uma matriz para transferência melhorada de moléculas osteoindutoras em reparo ósseo, implante ósseo, kit e uso
BR112019005318A2 (pt) compostos de aza-indazol para uso em lesões no tendão e/ou ligamento
BR112017010111A2 (pt) espaçador ("spacer") cerâmico para a troca bilateral de implantes em ombro, joelho e quadril como um resultado de infecções
BR112019007478A2 (pt) um novo método para a produção de sulfato de cálcio hemihidratado com propriedades únicas
BR112015011515A2 (pt) Composições farmacêuticas de inibidores de cetp
BR112014032583A2 (pt) forma farmacêutica para liberação prolongada de substâncias ativas
BR112015006727A8 (pt) uso de uma composição farmacêutica
BR112016001948A2 (pt) antagonistas de v1a para tratar distúrbios do sono de desvio de fase
CU20170066A7 (es) Productos a base de sulfato de calcio que comprende yeso y aceite de silicona y composiciones que los contienen
TR201004464A2 (tr) Kemik erimesi için formülasyon.
BR112019006087A2 (pt) composição de cuidados bucais e método para beneficiar dentes de um indivíduo

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/10/2017, OBSERVADAS AS CONDICOES LEGAIS